SAFE-BioPharma Publishes a Digital Signature Q&A with John Harris 

SIGNiX is increasing the accessibility and compliance of our digital signature solution by introducing digital identities that will adhere to the global standard set by SAFE-BioPharma ®. In a recent Q & A article in SAFE-BioPharma’s newsletter, our SVP of Product Management, John Harris, answered a few questions about how these enhancements will improve the biopharmaceutical industry.

In the article, John says, “The [SAFE-BioPharma®] - SIGNiX relationship ushers in the ability for life science organizations to take a single vendor approach… Both internal and external signers, using a trusted SAFE-BioPharma® credential can securely apply a digital signature anywhere, with any device.”

By using this enhanced digital signature, life sciences, pharmaceutical and healthcare companies are assured that they can authorize agreements that meet legal and regulatory requirements- like 21CFR Part 11- around the globe.

SIGNiX’s new SAFE-BioPharma®-compliant technology uses the most trusted levels of identity authentication and provides a unique digital certificate, or identity, certified by SAFE-BioPharma®. Signatures made with these certificates will be recognized and trusted by U.S. government agency applications and within Europe and the European Medicines Agency as a qualified electronic signature.

One of the questions we would like to highlight is:

                What advantage does the SIGNiX platform offer life sciences users?

The SIGNiX platform is totally flexible and convenient for applying a signature to any electronic document. SIGNiX’s patented technology, by default, enables digital signatures at a price that competes with less secure electronic signatures. Using the same technology and workflow, you can turn the dial up to a fully secure signature, compliant with the SAFE-BioPharma standard or down to sign non-regulatory contracts, always using digital signatures. It truly simplifies the process.

   Click here to read the full article.

 Discover the benefits of e-signatures for pharma and download our white paper today!